Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by bionicjoeon Apr 24, 2019 4:57pm
122 Views
Post# 29666336

RE:RE:RE:RE:RE:RE:May 14th earnings

RE:RE:RE:RE:RE:RE:May 14th earnings
Homestretch4me wrote: $60 is a chronic crack pipe example. $20 is a regular crack pipe example. A $20 price on your stock would give you almost the same valuation as canopy with half the sales, no us footprint and a management team that pales in comparison to canopies. Your management team cannot deliver and that's why you have no deal. The used shares like Monopoly money early on in the game to try and become the market leader. It failed miserably. Aurora is a distant second to canopy and may not hold on to Second Place much longer when some of the mso's in the US get a little more traction. Just say no........... To crack.
bionicjoe wrote:
Homestretch4me wrote: $60 share price??? Are you smoking the crack pipe? Do you not know that Aurora has over a billion shares outstanding and a $60 share price would give you a market cap North of 60 billion dollars, triple that of canopy with half the sales of canopy. Put down the crack pipe my friend and stop investing when you're high. Oh my God the people on this board keep getting dumber and dumber
bionicjoe wrote: Those figures are nice but without a major partner(s) Aurora will be fighting the fight to gain market sentiment with 1 arm tied behind it's back. The long shareholder is not here to see a $14 or $15 sp but one in the $20s and climbing It's commendable that management has chosen to maintain control of the company by not selling out to a large multinational but until investors see tangible progress on the partnership front the market will still have doubts if they can get it done. I'm sure investors would be willing to trade off selling 50% of the company like Canopy did if it means a $60 sp. Let's hope this multi-partner concept works because it's our money on the line.

 


Don't get excited or we'll have to call your mother to come get you. The $60 bucks was just an example. No reason to get your shorts in a knot. I'm sure you caught the drift of my post. To get the sp results Canopy shareholders are enjoying there must a partnership deal(s) with a big established multinational. You can have all the good analyst reviews you want but without a consummated deal Aurora won't be seen by investors as whole. We have now attracted the penny day traders who are ready to ditch the stock at a moment's notice while Canopy gathers in serious investors with dollars to spend to keep driving up its sp. Cam Battley is a great promotor but his story of wait and be amazed is getting old even with shareholders, nevermind the market.




LOL, what has Canopy done bigger and better than Aurora that isn't the result of the Constellation Brands deal? If it wasn't for the cash transfusion received by selling 50% of itself in that deal Canopy's share count now would be a billion also. Maybe Canopy got lucky because since then no other multinational has jumped in to the degree Constellation has.

Bullboard Posts